Arrowhead’s ARC-AAT Granted EMA Orphan Drug Designation
Go back to Arrowhead’s ARC-AAT Granted EMA Orphan Drug Designation| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 71.65 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $71.65 | 52 Week High | $8.22 | |||
| Open | $71.65 | 52 Week Low | $3.07 | |||
| Day High | $71.65 | P/E | N/A | |||
| Day Low | $71.65 | EPS | $-1.30 | |||
| Volume | 2 | |||||
